Oxford University Government began collaboration to track Covid-19 in UK population launched
On Apr. 23, 2020, researchers from the University of Oxford are supporting a new government study to track…
AstraZeneca and Saint Lukeﾒs Mid America Heart Institute initiated phase III DARE-19 trial with Farxiga in COVID-19 patients
On Apr. 23, 2020, AstraZeneca and and Saint Lukeﾒs Mid America Heart Institute initiated a randomised, global Phase…
Oxford University and Guangdong Centre for Diseases Control and Prevention use virus genomic tracking to reveal rise and fall of COVID-19 epidemic
On Apr. 23, 2020, a study led by researchers at Oxford and Guangdong Centre for Diseases Control and…
Key nose cells identified as likely COVID-19 entry points
On Apr. 23, 2020, the Wellcome Sanger Institute announced that two specific cell types in the nose has…
TGen contributed to international studies identifying cell-types susceptible to SARS-CoV-2 infection
On Apr. 23, 2020, two significant international studies involving hundreds of scientists, including a human geneticist at the…
CareDx and Johns Hopkins partnered on AlloSure lung surveillance for severe COVID-19 patients
On Apr. 23, 2020, CareDx and Johns Hopkins University announced the launch of the ALARM (AlloSure Lung Allograft…
Baxter obtained FDA Emergency Use Authorization for Oxiris blood purification filter for COVID-19 treatment
On Apr. 23, 2020, Baxter announced it had received emergency use authorization (EUA) from the FDA for the…
Yale launched clinical trial for drug to treat severe COVID-19 patients
On Apr. 23, 2020, Yale researchers began a clinical trial at Yale New Haven Hospital to test the…
The FDA issued an emergency use authorization (EUA) for the Philips Medizin Systeme Boeblingen
On Apr. 22, 2020, the FDA issued an emergency use authorization (EUA) for the Philips Medizin Systeme Boeblingen…
Catalent Biologics completed $14 million commercial packaging expansion at its Bloomington, Indiana facility
On Apr. 23, 2020, Catalent announced the completion of its $14 million expansion to increase the biologics packaging…
Johnson & Johnson announced collaboration to expand manufacturing capabilities for its COVID-19 vaccine candidate
On Apr. 23, 2020, Johnson & Johnson announced a collaboration between the Janssen Pharmaceutical of Johnson & Johnson…
Brensocatib (formerly INS1007) to be studied in patients with severe COVID-19 in investigator-initiated trial
On Apr. 23, 2020, Insmed announced that it will provide funding and clinical drug supply for the STOP-COVID19…
The USDA confirmed COVID-19 in two pet cats in New York
On Apr. 22, 2020, the CDC and the USDA National Veterinary Services Laboratories announced the first confirmed cases…
SNBL announced participation in development of a prophylactic DNA vaccine for COVID-19
On Apr. 20, 2020, SNBL announced their intention to participate in the development of a prophylactic DNA vaccine…
FDA granted ALung Emergency Use Authorization to Hemolung Respiratory Assist System for treatment of COVID-19
On Apr. 22, 2020, ALung Technologies announced the U.S. Food and Drug Administration (FDA) granted the Company Emergency…
BioNTech and Pfizer announced regulatory approval from German authority to commence first clinical trial of COVID-19 vaccine candidates
On Apr. 22, 2020, BioNTech and Pfizer announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the…
UTSW researchers reported heart cells can rejuvenate and multiply to heal damage
On Apr. 22, 2020, UT Southwestern Medical Center scientists announced they had discovered a protein that works with…
Virginia Tech researchers developed new COVID-19 tests to combat backlogs, shortages
On Apr. 22, 2020, Virginia Tech scientists annunced they had developed a new COVID-19 test and secured federal…
Immunic reported that IMU-838 demonstrated Preclinical activity against SARS-CoV-2 and explores plans for phase 2 clinical trial in COVID-19 patients
On Apr. 21, 2020, Immunic reported that its lead asset, IMU-838, a selective oral DHODH inhibitor successfully demonstrated…
Bayer partnered with Population Health Research Institute on global clinical research evaluating COVID-19 treatments
On Apr. 21, 2020, Bayer Mississauga, Ontario announced a partnership with the Population Health Research Institute (PHRI) to…
National Science Foundation awarded rapid response grants to support coronavirus (COVID-19) research
On Apr. 21, 2020, the National Science Foundation (NSF) issued a letter to researchers inviting proposals for rapid…
Vaxart announced positive preclinical data for ioral COVID-19 vaccine program
On Apr. 21, 2020, Vaxart announced it had obtained positive pre-clinical results for its COVID-19 vaccine candidates, with…
aTyr Pharma announced phase 2 study of ATYR1923 in COVID-19 patients with severe respiratory complications
On Apr. 21, 2020, aTyr Pharma announced the FDA has accepted its Investigational New Drug application to evaluate…
OpGen subsidiary Curetis GmbH and Karolinska Institutet collaborated in study of bacterial Co-infections in COVID-19 pneumonia patients
On Apr. 21, 2020, OpGen announced the start of an investigator initiated collaboration with Karolinska Institutet, Sweden, to…
LabCorp COVID-19 at-home test kit received FDA Emergency Use Authorization
On Apr. 21, 2020, LabCorpﾮ announced it has received an Emergency Use Authorization (EUA) from the FDA. The…
Quest Diagnostics began performing COVID-19 antibody testing
On Apr. 21, 2020, Quest Diagnostics announced that it has begun to perform antibody testing for coronavirus (COVID-19)…
New virus detection process under development at Rutgers-Camden
On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers UniversityﾖCamden research laboratory, where chemistry…
Atossa Therapeutics submitted Clinical Investigation approval to FDA for launch of COVID-19 HOPE study
On Apr. 20, 2020, Atossa Therapeutics announced that it had applied to the FDA for approval to commence…
Alexion announced plans to initiate phase 3 study of ULTOMIRISﾮ (ravulizumab-cwvz) in hospitalized patients with severe COVID-19
On Apr. 20, 2020, Alexion announced plans to initiate a global Phase 3 study to investigate ULTOMIRISﾮ (ravulizumab-cwvz)…
Screening of 11,552 compounds identified Innovation Pharma’s Brilacidin as promising Potential inhibitors of novel Coronavirus COVID-19
On Apr. 20, 2020, Innovation Pharma reported that based on molecular screening of 11,552 compounds comprising already FDA-approved…